Galmed Pharmaceuticals Ltd.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024
GLMD$0.300.2%1558$2$0.44-31.6%

Contact Information

Galmed Pharmaceuticals Ltd.
16 Tiomkin Street
Tel Aviv 6578317
Israel

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide.
Our corporate headquarters is located in Tel Aviv, Israel.